Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05549050
Other study ID # 21-10-1072
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date July 8, 2022
Est. completion date July 2023

Study information

Verified date September 2022
Source Indonesia University
Contact Henny A Puspitasari, dr. Sp.A(K)
Phone +6281218603930
Email henny.adriani01@ui.ac.id
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study aimed to discuss the correlation between interdialytic weight gain and cardiovascular diseases in children with end-stage kidney disease undergoing chronic hemodialysis. The cardiovascular parameters used include left ventricular hypertrophy, systolic and diastolic function, carotid intima-media thickness, myocardial circumferential strain, and strain rate.


Recruitment information / eligibility

Status Recruiting
Enrollment 75
Est. completion date July 2023
Est. primary completion date March 2023
Accepts healthy volunteers No
Gender All
Age group 2 Years to 18 Years
Eligibility Inclusion Criteria: - End-stage kidney disease (chronic kidney disease stage 5) - Undergo hemodialysis at least twice a week Exclusion Criteria: - History of congenital heart disease - Critically ill patients with unstable hemodynamic status

Study Design


Related Conditions & MeSH terms


Intervention

Other:
interdialytic weight gain
interdialytic weight gain during hemodialysis

Locations

Country Name City State
Indonesia Cipto Mangunkusumo Hospital Jakarta Pusat Jakarta

Sponsors (1)

Lead Sponsor Collaborator
Indonesia University

Country where clinical trial is conducted

Indonesia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Correlation between interdialytic weight gain and cardiovascular diseases in children with end-stage kidney disease undergoing hemodialysis Correlation between interdialytic weight gain and cardiovascular diseases in children with end-stage kidney disease undergoing hemodialysis Through study completion, an average of 1 year
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05978479 - The Effect of Individualized Education Using the Teach-Back Method Treatment on Treatment Adherence and the Coping Skills N/A
Completed NCT06022835 - Chlorhexidine Gluconate-gel Dressing for Exit Site Infection in Peritoneal Dialysis N/A
Completed NCT05540457 - Evaluation of Non-Invasive Continuous vs Intermittent BloodPressure Monitors in Maintenance Dialysis (BP Dialysis) N/A
Recruiting NCT04046042 - Virtual Reality Intradialysis: Last vs. First Part of the Session N/A
Not yet recruiting NCT04527640 - Effects of Synbiotics Supplementation on the Uremic Toxin Indoxyl Sulfate Level and Constipation in End-stage Renal Disease Patients Undergoing Hemodialysis N/A
Completed NCT05947708 - The Study of Intradialytic Symptoms in Subjects Treated With Qd 500vs Qd 300 N/A
Recruiting NCT05735743 - MoVE Trial: Motivational Strategies to Empower African Americans to Improve Dialysis Adherence N/A
Completed NCT04505462 - Dietary Therapy in Dialysis Patients N/A
Active, not recruiting NCT04546958 - Nutritional Interventions in Peritoneal Dialysis Patients With Hypoalbuminemia N/A
Recruiting NCT04286477 - The Immune System in End Stage CKD Patients - Comparison Among Different Modalities of RRT
Completed NCT04487301 - A Cross-Sectional Study to Assess Walking Performance in Subjects With Peripheral Artery and End Stage Kidney Disease
Recruiting NCT05677555 - Colchicine and Inflammation in Hemodialysis Patients Phase 2
Completed NCT04789876 - Effectiveness of The Phosphate Mobile App on Serum Phosphorus in Adult Hemodialysis Patients With Hyperphosphatemia N/A
Completed NCT04125537 - Pathways Project: Kidney Supportive Care
Suspended NCT05915286 - Diuretic Use in Hemodialysis Patients With Residual Renal Function Phase 4
Completed NCT04912050 - EXtension of Tablo TrEatmeNt Duration Registry
Recruiting NCT04360694 - RandomizEd ClinicAL triaL on the Efficacy and saFety of Incremental Hemodialysis (REAL-LIFE) N/A
Recruiting NCT04501159 - pH, Hypoxia and Haemodialysis
Recruiting NCT05032651 - Use of a Novel Artificial Intelligence Assisted Platform to Assess Optimal Dosing and Treatment Strategy of Erythropoiesis-stimulating Agents (ESA) in Hemodialysis Patients N/A
Completed NCT04806126 - Evaluation of a Virtual Home Dialysis Mentoring Program (Home)